Loading...

Xylem

DB:XY6
Snowflake Description

Proven track record with moderate growth potential.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
XY6
DB
$15B
Market Cap
  1. Home
  2. DE
  3. Capital Goods
Company description

Xylem Inc. engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications. The last earnings update was 74 days ago. More info.


Add to Portfolio Compare Print
XY6 Share Price and Events
7 Day Returns
0.7%
DB:XY6
-4.2%
DE Machinery
-1.8%
DE Market
1 Year Returns
24.4%
DB:XY6
-28.7%
DE Machinery
-6.7%
DE Market
XY6 Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Xylem (XY6) 0.7% 3.5% 0.7% 24.4% 71.1% 164.4%
DE Machinery -4.2% -7.8% -14.2% -28.7% -20.9% 1.9%
DE Market -1.8% 1.6% -1.6% -6.7% 10.1% 11%
1 Year Return vs Industry and Market
  • XY6 outperformed the Machinery industry which returned -28.7% over the past year.
  • XY6 outperformed the Market in Germany which returned -6.7% over the past year.
Price Volatility
XY6
Industry
5yr Volatility vs Market

XY6 Value

 Is Xylem undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Xylem to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Xylem.

DB:XY6 Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 16 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 7.1%
Perpetual Growth Rate 10-Year DE Government Bond Rate 0.2%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for DB:XY6
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year DE Govt Bond Rate 0.2%
Equity Risk Premium S&P Global 6%
Machinery Unlevered Beta Simply Wall St/ S&P Global 1.09
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 1.086 (1 + (1- 21%) (17.54%))
1.159
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
1.16
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 0.23% + (1.159 * 5.96%)
7.13%

Discounted Cash Flow Calculation for DB:XY6 using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Xylem is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

DB:XY6 DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (USD, Millions) Source Present Value
Discounted (@ 7.13%)
2020 707.40 Analyst x8 660.30
2021 791.53 Analyst x4 689.63
2022 885.55 Analyst x2 720.19
2023 913.00 Analyst x1 693.07
2024 933.15 Est @ 2.21% 661.20
2025 948.20 Est @ 1.61% 627.14
2026 959.55 Est @ 1.2% 592.39
2027 968.25 Est @ 0.91% 557.96
2028 975.06 Est @ 0.7% 524.48
2029 980.52 Est @ 0.56% 492.30
Present value of next 10 years cash flows $6,218.67
DB:XY6 DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2029 × (1 + g) ÷ (Discount Rate – g)
= $980.52 × (1 + 0.23%) ÷ (7.13% – 0.23%)
$14,232.82
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= $14,232.82 ÷ (1 + 7.13%)10
$7,146.00
DB:XY6 Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= $6,218.67 + $7,146.00
$13,364.67
Equity Value per Share
(USD)
= Total value / Shares Outstanding
= $13,364.67 / 179.93
$74.28
DB:XY6 Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in DB:XY6 represents 0.89733x of NYSE:XYL
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.89733x
Value per Share
(Listing Adjusted, EUR)
= Value per Share (USD) x Listing Adjustment Factor
= $ 74.28 x 0.89733
€66.65
Value per share (EUR) From above. €66.65
Current discount Discount to share price of €73.50
= -1 x (€73.50 - €66.65) / €66.65
-10.3%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

  • The current share price of Xylem is above its future cash flow value.
Often investors are willing to pay a premium for a company that has a high dividend or the potential for future growth.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Xylem's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Xylem's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
DB:XY6 PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-03-31) in USD $3.05
NYSE:XYL Share Price ** NYSE (2019-07-15) in USD $81.91
Germany Machinery Industry PE Ratio Median Figure of 37 Publicly-Listed Machinery Companies 14.36x
Germany Market PE Ratio Median Figure of 419 Publicly-Listed Companies 20.05x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Xylem.

DB:XY6 PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NYSE:XYL Share Price ÷ EPS (both in USD)

= 81.91 ÷ 3.05

26.82x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Xylem is overvalued based on earnings compared to the DE Machinery industry average.
  • Xylem is overvalued based on earnings compared to the Germany market.
Price based on expected Growth
Does Xylem's expected growth come at a high price?
Raw Data
DB:XY6 PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 26.82x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 16 Analysts
12.3%per year
Germany Machinery Industry PEG Ratio Median Figure of 29 Publicly-Listed Machinery Companies 1.29x
Germany Market PEG Ratio Median Figure of 270 Publicly-Listed Companies 1.47x

*Line of best fit is calculated by linear regression .

DB:XY6 PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 26.82x ÷ 12.3%

2.19x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Xylem is poor value based on expected growth next year.
Price based on value of assets
What value do investors place on Xylem's assets?
Raw Data
DB:XY6 PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-03-31) in USD $15.54
NYSE:XYL Share Price * NYSE (2019-07-15) in USD $81.91
Germany Machinery Industry PB Ratio Median Figure of 47 Publicly-Listed Machinery Companies 1.5x
Germany Market PB Ratio Median Figure of 565 Publicly-Listed Companies 1.74x
DB:XY6 PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NYSE:XYL Share Price ÷ Book Value per Share (both in USD)

= 81.91 ÷ 15.54

5.27x

* Primary Listing of Xylem.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Xylem is overvalued based on assets compared to the DE Machinery industry average.
X
Value checks
We assess Xylem's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Machinery industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Machinery industry average (and greater than 0)? (1 check)
  5. Xylem has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

XY6 Future Performance

 How is Xylem expected to perform in the next 1 to 3 years based on estimates from 16 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
12.3%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Xylem expected to grow at an attractive rate?
  • Xylem's earnings growth is expected to exceed the low risk savings rate of 0.2%.
Growth vs Market Checks
  • Xylem's earnings growth is expected to exceed the Germany market average.
  • Xylem's revenue growth is positive but not above the Germany market average.
Annual Growth Rates Comparison
Raw Data
DB:XY6 Future Growth Rates Data Sources
Data Point Source Value (per year)
DB:XY6 Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 16 Analysts 12.3%
DB:XY6 Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 16 Analysts 4.8%
Germany Machinery Industry Earnings Growth Rate Market Cap Weighted Average 11.2%
Germany Machinery Industry Revenue Growth Rate Market Cap Weighted Average 5.5%
Germany Market Earnings Growth Rate Market Cap Weighted Average 12.1%
Germany Market Revenue Growth Rate Market Cap Weighted Average 5.1%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
DB:XY6 Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 16 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
DB:XY6 Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2023-12-31 6,501 1,140 846 1
2022-12-31 6,210 1,103 809 2
2021-12-31 5,937 1,039 733 7
2020-12-31 5,665 939 656 16
2019-12-31 5,379 832 535 16
DB:XY6 Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-03-31 5,227 606 549
2018-12-31 5,207 586 549
2018-09-30 5,098 695 395
2018-06-30 5,006 736 370
2018-03-31 4,853 697 354
2017-12-31 4,707 686 331
2017-09-30 4,525 602 310
2017-06-30 4,227 523 278
2017-03-31 3,995 508 250
2016-12-31 3,771 497 260
2016-09-30 3,670 478 324
2016-06-30 3,675 466 339

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Xylem's earnings are expected to grow by 12.3% yearly, however this is not considered high growth (20% yearly).
  • Xylem's revenue is expected to grow by 4.8% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
DB:XY6 Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 16 Analyst Estimates (S&P Global) See Below

All data from Xylem Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:XY6 Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2023-12-31 5.60 5.60 5.60 1.00
2022-12-31 4.79 5.00 4.57 2.00
2021-12-31 4.18 4.45 4.01 4.00
2020-12-31 3.65 3.85 3.39 12.00
2019-12-31 2.91 3.09 2.75 10.00
DB:XY6 Past Financials Data
Date (Data in USD Millions) EPS *
2019-03-31 3.05
2018-12-31 3.05
2018-09-30 2.20
2018-06-30 2.06
2018-03-31 1.97
2017-12-31 1.84
2017-09-30 1.73
2017-06-30 1.55
2017-03-31 1.39
2016-12-31 1.45
2016-09-30 1.81
2016-06-30 1.89

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Xylem is expected to efficiently use shareholders’ funds in the future (Return on Equity greater than 20%).
X
Future performance checks
We assess Xylem's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Germany market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Germany market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Xylem has a total score of 3/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

XY6 Past Performance

  How has Xylem performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Xylem's growth in the last year to its industry (Machinery).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Xylem's year on year earnings growth rate has been positive over the past 5 years.
  • Xylem's 1-year earnings growth exceeds its 5-year average (55.1% vs 9.1%)
  • Xylem's earnings growth has exceeded the DE Machinery industry average in the past year (55.1% vs -1.3%).
Earnings and Revenue History
Xylem's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Xylem Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:XY6 Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-03-31 5,227.00 549.00 1,159.00 199.00
2018-12-31 5,207.00 549.00 1,150.00 189.00
2018-09-30 5,098.00 395.00 1,158.00 186.00
2018-06-30 5,006.00 370.00 1,133.00 185.00
2018-03-31 4,853.00 354.00 1,092.00 180.00
2017-12-31 4,707.00 331.00 1,072.00 181.00
2017-09-30 4,525.00 310.00 1,023.00 166.00
2017-06-30 4,227.00 278.00 983.00 144.00
2017-03-31 3,995.00 250.00 939.00 127.00
2016-12-31 3,771.00 260.00 895.00 110.00
2016-09-30 3,670.00 324.00 878.00 99.00
2016-06-30 3,675.00 339.00 876.00 99.00
2016-03-31 3,663.00 342.00 867.00 97.00
2015-12-31 3,653.00 340.00 854.00 95.00
2015-09-30 3,701.00 322.00 846.00 97.00
2015-06-30 3,762.00 340.00 861.00 98.00
2015-03-31 3,847.00 352.00 885.00 100.00
2014-12-31 3,916.00 337.00 920.00 104.00
2014-09-30 3,907.00 309.00 901.00 104.00
2014-06-30 3,909.00 276.00 929.00 104.00
2014-03-31 3,864.00 236.00 925.00 105.00
2013-12-31 3,837.00 228.00 942.00 104.00
2013-09-30 3,773.00 233.00 951.00 104.00
2013-06-30 3,739.00 232.00 931.00 104.00
2013-03-31 3,745.00 275.00 913.00 104.00
2012-12-31 3,791.00 297.00 914.00 106.00
2012-09-30 3,825.00 276.00 912.00 107.00

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Xylem has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Xylem used its assets more efficiently than the DE Machinery industry average last year based on Return on Assets.
  • Xylem's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Xylem's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Machinery industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Xylem has a total score of 4/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

XY6 Health

 How is Xylem's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Xylem's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Xylem is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Xylem's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of Xylem's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is not covered by short term assets, assets are 0.9x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Xylem Company Filings, last reported 3 months ago.

DB:XY6 Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-03-31 2,808.00 2,348.00 275.00
2018-12-31 2,782.00 2,308.00 296.00
2018-09-30 2,631.00 2,531.00 404.00
2018-06-30 2,529.00 2,540.00 321.00
2018-03-31 2,557.00 2,599.00 297.00
2017-12-31 2,519.00 2,200.00 414.00
2017-09-30 2,480.00 2,286.00 283.00
2017-06-30 2,382.00 2,411.00 288.00
2017-03-31 2,268.00 2,387.00 287.00
2016-12-31 2,207.00 2,368.00 308.00
2016-09-30 2,227.00 1,210.00 659.00
2016-06-30 2,174.00 1,234.00 586.00
2016-03-31 2,159.00 1,873.00 1,193.00
2015-12-31 2,084.00 1,274.00 680.00
2015-09-30 2,043.00 1,275.00 611.00
2015-06-30 2,080.00 1,277.00 600.00
2015-03-31 1,989.00 1,276.00 554.00
2014-12-31 2,127.00 1,284.00 663.00
2014-09-30 2,193.00 1,240.00 529.00
2014-06-30 2,245.00 1,242.00 450.00
2014-03-31 2,229.00 1,243.00 466.00
2013-12-31 2,241.00 1,241.00 533.00
2013-09-30 2,158.00 1,202.00 394.00
2013-06-30 2,052.00 1,204.00 360.00
2013-03-31 2,040.00 1,205.00 375.00
2012-12-31 2,074.00 1,205.00 504.00
2012-09-30 2,054.00 1,212.00 424.00
  • Xylem's level of debt (83.6%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (55.8% vs 83.6% today).
  • Debt is well covered by operating cash flow (25.8%, greater than 20% of total debt).
  • Interest payments on debt are well covered by earnings (EBIT is 9.2x coverage).
X
Financial health checks
We assess Xylem's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Xylem has a total score of 3/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

XY6 Dividends

 What is Xylem's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
1.17%
Current annual income from Xylem dividends. Estimated to be 1.34% next year.
If you bought €2,000 of Xylem shares you are expected to receive €23 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Xylem's pays a lower dividend yield than the bottom 25% of dividend payers in Germany (1.48%).
  • Xylem's dividend is below the markets top 25% of dividend payers in Germany (3.85%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
DB:XY6 Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 16 Analyst Estimates (S&P Global) See Below
Germany Machinery Industry Average Dividend Yield Market Cap Weighted Average of 30 Stocks 2.3%
Germany Market Average Dividend Yield Market Cap Weighted Average of 325 Stocks 3.1%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.8%
Germany Bottom 25% Dividend Yield 25th Percentile 1.5%
Germany Top 25% Dividend Yield 75th Percentile 3.9%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

DB:XY6 Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2023-12-31 1.63 1.00
2022-12-31 1.21 2.00
2021-12-31 1.21 5.00
2020-12-31 1.09 9.00
2019-12-31 0.96 9.00
DB:XY6 Past Annualized Dividends Data
Date (Data in $) Dividend per share (annual) Avg. Yield (%)
2019-05-16 0.960 1.212
2019-05-02 0.960 1.225
2019-02-22 0.960 1.214
2019-01-31 0.960 1.331
2018-10-11 0.840 1.235
2018-08-16 0.840 1.077
2018-05-10 0.840 1.186
2018-02-01 0.840 1.118
2017-10-12 0.720 1.060
2017-08-17 0.720 1.150
2017-05-11 0.720 1.307
2017-05-02 0.720 1.405
2017-02-23 0.720 1.455
2017-02-02 0.720 1.504
2016-10-13 0.620 1.235
2016-08-17 0.620 1.218
2016-05-13 0.620 1.348
2016-05-03 0.620 1.468
2016-02-26 0.620 1.539
2016-02-04 0.620 1.671
2015-10-29 0.563 1.564
2015-05-13 0.563 1.627
2015-04-30 0.563 1.531
2015-02-26 0.563 1.588
2015-02-05 0.563 1.581
2014-10-15 0.512 1.408
2014-08-25 0.512 1.413
2014-05-07 0.512 1.364
2014-04-29 0.512 1.385
2014-02-27 0.512 1.396
2014-02-04 0.512 1.355
2013-10-10 0.466 1.407
2013-08-21 0.466 1.752
2013-05-08 0.466 1.715
2013-02-07 0.466 1.671
2012-10-12 0.405 1.549
2012-08-20 0.405 1.623
2012-05-10 0.405 1.641
2012-02-24 0.405 1.484
2011-11-02 0.405 1.599

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Whilst dividend payments have been stable, Xylem has been paying a dividend for less than 10 years.
  • Dividend payments have increased, but Xylem only paid a dividend in the past 8 years.
Current Payout to shareholders
What portion of Xylem's earnings are paid to the shareholders as a dividend.
  • Dividends paid are well covered by earnings (3.5x coverage).
Future Payout to shareholders
  • Dividends after 3 years are expected to be well covered by earnings (3.6x coverage).
X
Income/ dividend checks
We assess Xylem's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Xylem afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Xylem has a total score of 2/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

XY6 Management

 What is the CEO of Xylem's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Patrick Decker
COMPENSATION $8,327,670
AGE 54
TENURE AS CEO 5.3 years
CEO Bio

Mr. Patrick K. Decker has been the Chief Executive Officer and President of Xylem Inc. since March 17, 2014. Mr. Decker served as the Chief Executive Officer and President of Harsco Corporation from September 10, 2012 to March 2014. He served as the President of Tyco Flow Control Inc. from June 2007 to August 2012. He served as the Head of Tyco Flow Control of Tyco Fire & Security, LLC. He joined Tyco in May 2003 as the Chief Financial Officer of Tyco's Plastics & Adhesives Business and also served as its Chief Financial Officer of the Engineered Products and Services business since January 2005. He served as the President of Tyco Flow Control International Ltd., until August 8, 2012. Prior to Tyco, Mr. Decker served 13 years at Bristol-Myers Squibb in a series of key finance roles both in the U.S. and internationally, including Vice President of Finance and Business Development for the Mead Johnson Nutritionals business. He began his career as an Auditor for Price Waterhouse Coopers. He has been a Director of Xylem Inc. since March 17, 2014. He served as Director of Harsco Corporation from October 29, 2012 to March 2014. He is a Certified Public Accountant. Mr. Decker holds a BS in Accounting and Finance from Indiana University.

CEO Compensation
  • Patrick's compensation has been consistent with company performance over the past year, both up more than 20%.
  • Patrick's remuneration is higher than average for companies of similar size in Germany.
Management Team Tenure

Average tenure and age of the Xylem management team in years:

4.4
Average Tenure
54.5
Average Age
  • The tenure for the Xylem management team is about average.
Management Team

Patrick Decker

TITLE
President
COMPENSATION
$8M
AGE
54
TENURE
5.3 yrs

E. Rajkowski

TITLE
Senior VP & CFO
COMPENSATION
$3M
AGE
60
TENURE
3.3 yrs

Claudia Toussaint

TITLE
Senior VP
COMPENSATION
$2M
AGE
55
TENURE
4.8 yrs

Colin Sabol

TITLE
Senior VP and President of Measurement & Control Solutions
COMPENSATION
$2M
AGE
51
TENURE
8.5 yrs

Ken Napolitano

TITLE
Senior VP and President of Applied Water Systems & Americas Commercial Team
COMPENSATION
$2M
AGE
57
TENURE
8.5 yrs

Geri-Michelle McShane

TITLE
VP, Controller & Chief Accounting Officer
AGE
45
TENURE
0.3 yrs

Jay Iyengar

TITLE
Chief Innovation & Technology Officer and Senior VP
TENURE
4.1 yrs

Jason Chapman

TITLE
Interim Chief Information Officer & VP of Global Business Services
TENURE
1.8 yrs

Matt Latino

TITLE
Director of Investor Relations
TENURE
1.8 yrs

Kelly McAndrew

TITLE
Vice President of Global Public Affairs
TENURE
4.8 yrs
Board of Directors Tenure

Average tenure and age of the Xylem board of directors in years:

7.8
Average Tenure
65.5
Average Age
  • The tenure for the Xylem board of directors is about average.
Board of Directors

Markos Tambakeras

TITLE
Chairman of the Board
COMPENSATION
$375K
AGE
68
TENURE
7.8 yrs

Patrick Decker

TITLE
President
COMPENSATION
$8M
AGE
54
TENURE
5.3 yrs

Steve Loranger

TITLE
Independent Director
COMPENSATION
$255K
AGE
67
TENURE
7.8 yrs

Curt Crawford

TITLE
Independent Director
COMPENSATION
$244K
AGE
71
TENURE
7.8 yrs

Victoria Harker

TITLE
Independent Director
COMPENSATION
$260K
AGE
54
TENURE
7.8 yrs

Rob Friel

TITLE
Independent Director
COMPENSATION
$255K
AGE
63
TENURE
6.6 yrs

Jerome Peribere

TITLE
Independent Director
COMPENSATION
$251K
AGE
64
TENURE
6.2 yrs

Surya Mohapatra

TITLE
Independent Director
COMPENSATION
$240K
AGE
69
TENURE
7.8 yrs

Sten Jakobsson

TITLE
Independent Director
COMPENSATION
$240K
AGE
70
TENURE
7.8 yrs

Jeanne Beliveau-Dunn

TITLE
Director
COMPENSATION
$240K
AGE
59
TENURE
1.9 yrs
Who owns this company?
Recent Insider Trading
  • Xylem individual insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
08. May 19 Sell Curtis Crawford Individual 07. May 19 07. May 19 -7,500 €70.81 €-531,078
18. Mar 19 Sell Steven Loranger Individual 15. Mar 19 15. Mar 19 -10,000 €68.00 €-679,991
18. Mar 19 Sell Curtis Crawford Individual 14. Mar 19 14. Mar 19 -7,500 €67.78 €-508,318
26. Feb 19 Sell Tomas Brannemo Individual 26. Feb 19 26. Feb 19 -2,621 €66.03 €-173,059
22. Feb 19 Sell Tomas Brannemo Individual 21. Feb 19 21. Feb 19 -559 €65.68 €-36,713
07. Aug 18 Sell Curtis Crawford Individual 03. Aug 18 07. Aug 18 -7,500 €65.99 €-493,498
07. Aug 18 Sell Kairus Tarapore Individual 03. Aug 18 03. Aug 18 -2,300 €64.80 €-149,049
X
Management checks
We assess Xylem's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Xylem has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

XY6 News

Simply Wall St News

XY6 Company Info

Description

Xylem Inc. engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications. It operates in three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation and treatment of water. The Applied Water segment provides pumps, valves, heat exchangers, controls, and dispensing equipment systems under the Goulds Water Technology, Bell & Gossett, A-C Fire Pump, Standard Xchange, Lowara, Jabsco, and Flojet brand names for residential and commercial building services, and industrial water applications. The Measurement & Control Solutions segment provides smart metering, networked communications, and measurement and control technologies, as well as critical infrastructure technologies that allow customers to use their distribution networks for the delivery, monitoring, and control of critical resources, such as water, electricity, and natural gas. It also offers software and services, including cloud-based analytics, remote monitoring, data management, leak detection, and pressure monitoring solutions and testing equipment, as well as sells smart lighting solutions. This segment sells its products under the EmNet, Pure, Sensus, Smith Blair, Valor Water, Visenti, WTW, and YSI brand names. The company markets and sells its products through a network of direct sales force, resellers, distributors, and value-added solution providers in the United States, Europe, the Asia Pacific, and internationally. Xylem Inc. is headquartered in Rye Brook, New York.

Details
Name: Xylem Inc.
XY6
Exchange: DB
Founded:
$13,187,830,028
179,933,009
Website: http://www.xylem.com
Address: Xylem Inc.
1 International Drive,
Rye Brook,
New York, 10573,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NYSE XYL Common Stock New York Stock Exchange US USD 13. Oct 2011
DB XY6 Common Stock Deutsche Boerse AG DE EUR 13. Oct 2011
LSE 0M29 Common Stock London Stock Exchange GB USD 13. Oct 2011
BMV XYL * Common Stock Bolsa Mexicana de Valores MX MXN 13. Oct 2011
Number of employees
Current staff
Staff numbers
17,000
Xylem employees.
Industry
Industrial Machinery
Capital Goods
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/07/15 21:38
End of day share price update: 2019/07/15 00:00
Last estimates confirmation: 2019/07/11
Last earnings filing: 2019/05/02
Last earnings reported: 2019/03/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.